Epidemiology of the endocrine orbitopathy;Endokrinná orbitopatia - Epidemiologické súvislosti

Ceska a Slovenska Oftalmologie

Volumn 62, Issue 6, 2006, Pages 373-380

  Čmelo, Jozef ^a   Chynoransky M ^b   Podoba, J ^c   Benejova Z ^d   Blaskova J ^a   Ferkova S ^b   Farkasova B ^a   Kalafutova I ^d   Kramplova K ^a   Lackova A ^d   Malacka D ^d   Micevova K ^a   Olahova S ^a   Petrakova E ^a   Podobova M ^d   Prokesova D ^d   Rybar M ^d   Ruzinakova S ^d   Smoradkova A ^a   Steklac J ^c   Valaskova T ^a   Veres, I ^d   more..

^a O ná Neurooftalmolgická Ambulancia   (Slovakia)

^b Klinika Oftalmologie LFUK   (Slovakia)

^c SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^d Endokrinologická Ambulancia   (Slovakia)

Author keywords

Endocrine orbitopathy; Epidemiological data; Intraocular pressure; Protrusion; Pseudoglaucoma

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FEMALE; GLAUCOMA; HUMAN; HYPERTHYROIDISM; INTRAOCULAR PRESSURE ABNORMALITY; MALE; PREVALENCE; PSEUDOGLAUCOMA;

EID: 33751502699     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Asman, P.: Ophthalmological evaluation in thyroid-associated ophthalmopathy. Acta Ophthalmol. Scan., 81, 2003, 5: 437-448
2. Bartalena, L., Pinchera, A., Marcocci, C.: Management of Graves' Ophthalmopathy: Reality and Perspectives. Endocrine Reviews, 21, 2000, 2, 168-199.
3. Bartley, G.B.: The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County. Transactions of the American Ophthalmological Society, 92, 1994, 477-588.
4. Ferková, S.: Diagnostika a liečba endokrinnej orbitopatie pri Graves Basedowej chorobe. Lek. listy, 5, 2003: 10-11.
5. Ferková, S.: Graves-Basedowa choroba a endokrinná orbitopatia. Lek. Listy, 5, 2003: 8-9.
6. Fierz, A., Landau, K.: Endocrine orbitopathy. Schweiz Rundsch Med. Prax, 17, 2001: 882-886
7. Kalmann, R., Mourits, M.P.: Prevalence and management of elevated intraocular pressure in patients with Graves' orbitopathy. Br. J. Ophthalmol., 82, 1998, 7: 754-757.
8. Kazim, M., Bagattini, M., Lupoli, G., et al.: Insight into pathogenesis of thyroid-associated orbitopathy. Arch. Ophthalmol., 120, 2002: 380-386.
9. Kendler, D.L., Lippa, J., Rootman, J.: The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Arch. Ophthalmol., 111, 1993, 2: 197-201.
10. Marcocci, C., Bartalena, L., Bogazzi, F., et al.: Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinologica, 120, 1989; 4: 473-478
11. Mourits, M.P., Prummel, M.E., Wiersinga, W.M., et al.: Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin. Endocrinol. (Oxf), 47, 1997, 1: 15.
12. Ohtsuka, K., Nakamura, Y.: Open-angle glaucoma associated with Graves disease. Am. J. Ophthalmol., 129, 2000, 5: 613-617.
13. Otradovec, J.: Choroby oěnice, Avicenum, Praha 1986, s. 214.
14. Perros, P., Crombie, A.L., Matthews, J.N., et al.: Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clinical Endocrinology, 38, 1993, 4: 367-372.
15. Poruban, D., Ábelovský, P., Vančo, M.: Modifikovaná cikcaková koronárna incízia. Choroby hlavy a krku, 6, 1997; 1: 17-19.
16. Prummel, M.F., Suttorp-Schulten, M.S., Wiersinga, W.M.: A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy. Ophthalmology, 100, 1993, 4: 556-561.
17. Vana, S., Nemec, J., Rezek, P., et al.: Significance of determination of antibodies to TSH receptors (using TRAK) in the diagnosis and monitoring of therapy in endocrine orbital disease, Vnitř. Lék, 40/10, 1994: 636-638.
18. Wiersinga, W.M., Smit, T., Van der Gaag, R., et al.: Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J. Endocrinol. Invest, 11, 1988, 8: 615-619.